The high prevalence of severe early posttransplant renal allograft pathology inhepatitis C positive recipients

Fernando G Cosio, Daniel D. Sedmak, Mitchell L. Henry, Chafik Al Haddad, Michael E. Falkenhain, Elmahdi A. Elkhammas, Elizabeth A. Davies, Ginny L. Bumgardner, Ronald M. Ferguson

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

In the USA approximately 10% of candidates for renal transplantation have serum antibodies to hepatitis C (HCV). To assess the possible impact of HCV infection on early posttransplant events we assessed allograft complications during the first 6 months following renal transplantation in three groups of adult renal allograft recipients: (1) HCV antibody positive recipients (R-HCV) (n=32); (2) HCV negative recipients who received kidneys from HCV antibody positive donors (D-HCV) (n=48); and (3) HCV negative recipients of HCV negative allografts who were transplanted during the same time period as R-HCV (Ctrl) (n=204). Allograft biopsies were done for evaluation of allograft dysfunction during the first 6 months posttransplant in 58% of Ctrl, 42% of D-HCV, and 63% of R-HCV (not significantly different). The prevalence of acute tubulointerstitial rejection was similar among the 3 groups of patients. In contrast, compared with Ctrl, both R-HCV and D-HCV had a significantly higher prevalence of acute transplant glomerulopathy (Ctrl, 6%; R-HCV, 55%, P<.0001; D-HCV 40%, P=.0004). Acute vascular rejection was more common in R-HCV (60%) than in Ctrl (28%) (P=.009) and the prevalence of chronic vascular rejection was also higher in R-HCV (60%) than in Ctrl (31%) (P=.01). Furthermore, chronic vascular rejection was diagnosed earlier in R- HCV(64% of cases within one month posttransplantation) than in Ctrl (19% within one month) (P=.01). Death censored renal allograft losses occurred in 14% of Ctrl, 17% of D-HCV, and 26% of R-HCV (not significant). In conclusion, R-HCV patients have a high prevalence of severe acute pathologic findings in renal allograft biopsies obtained early after transplantation and develop chronic vascular rejection more often and earlier than HCV negative recipients. These studies also confirm the previously reported association of HCV with acute transplant glomerulopathy.

Original languageEnglish (US)
Pages (from-to)1054-1059
Number of pages6
JournalTransplantation
Volume62
Issue number8
DOIs
StatePublished - Oct 27 1996
Externally publishedYes

Fingerprint

Allografts
Pathology
Kidney
Hepatitis C Antibodies
Blood Vessels
Kidney Transplantation
Transplants
Biopsy
Transplantation
Tissue Donors
Infection
Serum

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Cosio, F. G., Sedmak, D. D., Henry, M. L., Al Haddad, C., Falkenhain, M. E., Elkhammas, E. A., ... Ferguson, R. M. (1996). The high prevalence of severe early posttransplant renal allograft pathology inhepatitis C positive recipients. Transplantation, 62(8), 1054-1059. https://doi.org/10.1097/00007890-199610270-00004

The high prevalence of severe early posttransplant renal allograft pathology inhepatitis C positive recipients. / Cosio, Fernando G; Sedmak, Daniel D.; Henry, Mitchell L.; Al Haddad, Chafik; Falkenhain, Michael E.; Elkhammas, Elmahdi A.; Davies, Elizabeth A.; Bumgardner, Ginny L.; Ferguson, Ronald M.

In: Transplantation, Vol. 62, No. 8, 27.10.1996, p. 1054-1059.

Research output: Contribution to journalArticle

Cosio, FG, Sedmak, DD, Henry, ML, Al Haddad, C, Falkenhain, ME, Elkhammas, EA, Davies, EA, Bumgardner, GL & Ferguson, RM 1996, 'The high prevalence of severe early posttransplant renal allograft pathology inhepatitis C positive recipients', Transplantation, vol. 62, no. 8, pp. 1054-1059. https://doi.org/10.1097/00007890-199610270-00004
Cosio, Fernando G ; Sedmak, Daniel D. ; Henry, Mitchell L. ; Al Haddad, Chafik ; Falkenhain, Michael E. ; Elkhammas, Elmahdi A. ; Davies, Elizabeth A. ; Bumgardner, Ginny L. ; Ferguson, Ronald M. / The high prevalence of severe early posttransplant renal allograft pathology inhepatitis C positive recipients. In: Transplantation. 1996 ; Vol. 62, No. 8. pp. 1054-1059.
@article{0c27ce89ea534dba8659b6fb2562276f,
title = "The high prevalence of severe early posttransplant renal allograft pathology inhepatitis C positive recipients",
abstract = "In the USA approximately 10{\%} of candidates for renal transplantation have serum antibodies to hepatitis C (HCV). To assess the possible impact of HCV infection on early posttransplant events we assessed allograft complications during the first 6 months following renal transplantation in three groups of adult renal allograft recipients: (1) HCV antibody positive recipients (R-HCV) (n=32); (2) HCV negative recipients who received kidneys from HCV antibody positive donors (D-HCV) (n=48); and (3) HCV negative recipients of HCV negative allografts who were transplanted during the same time period as R-HCV (Ctrl) (n=204). Allograft biopsies were done for evaluation of allograft dysfunction during the first 6 months posttransplant in 58{\%} of Ctrl, 42{\%} of D-HCV, and 63{\%} of R-HCV (not significantly different). The prevalence of acute tubulointerstitial rejection was similar among the 3 groups of patients. In contrast, compared with Ctrl, both R-HCV and D-HCV had a significantly higher prevalence of acute transplant glomerulopathy (Ctrl, 6{\%}; R-HCV, 55{\%}, P<.0001; D-HCV 40{\%}, P=.0004). Acute vascular rejection was more common in R-HCV (60{\%}) than in Ctrl (28{\%}) (P=.009) and the prevalence of chronic vascular rejection was also higher in R-HCV (60{\%}) than in Ctrl (31{\%}) (P=.01). Furthermore, chronic vascular rejection was diagnosed earlier in R- HCV(64{\%} of cases within one month posttransplantation) than in Ctrl (19{\%} within one month) (P=.01). Death censored renal allograft losses occurred in 14{\%} of Ctrl, 17{\%} of D-HCV, and 26{\%} of R-HCV (not significant). In conclusion, R-HCV patients have a high prevalence of severe acute pathologic findings in renal allograft biopsies obtained early after transplantation and develop chronic vascular rejection more often and earlier than HCV negative recipients. These studies also confirm the previously reported association of HCV with acute transplant glomerulopathy.",
author = "Cosio, {Fernando G} and Sedmak, {Daniel D.} and Henry, {Mitchell L.} and {Al Haddad}, Chafik and Falkenhain, {Michael E.} and Elkhammas, {Elmahdi A.} and Davies, {Elizabeth A.} and Bumgardner, {Ginny L.} and Ferguson, {Ronald M.}",
year = "1996",
month = "10",
day = "27",
doi = "10.1097/00007890-199610270-00004",
language = "English (US)",
volume = "62",
pages = "1054--1059",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - The high prevalence of severe early posttransplant renal allograft pathology inhepatitis C positive recipients

AU - Cosio, Fernando G

AU - Sedmak, Daniel D.

AU - Henry, Mitchell L.

AU - Al Haddad, Chafik

AU - Falkenhain, Michael E.

AU - Elkhammas, Elmahdi A.

AU - Davies, Elizabeth A.

AU - Bumgardner, Ginny L.

AU - Ferguson, Ronald M.

PY - 1996/10/27

Y1 - 1996/10/27

N2 - In the USA approximately 10% of candidates for renal transplantation have serum antibodies to hepatitis C (HCV). To assess the possible impact of HCV infection on early posttransplant events we assessed allograft complications during the first 6 months following renal transplantation in three groups of adult renal allograft recipients: (1) HCV antibody positive recipients (R-HCV) (n=32); (2) HCV negative recipients who received kidneys from HCV antibody positive donors (D-HCV) (n=48); and (3) HCV negative recipients of HCV negative allografts who were transplanted during the same time period as R-HCV (Ctrl) (n=204). Allograft biopsies were done for evaluation of allograft dysfunction during the first 6 months posttransplant in 58% of Ctrl, 42% of D-HCV, and 63% of R-HCV (not significantly different). The prevalence of acute tubulointerstitial rejection was similar among the 3 groups of patients. In contrast, compared with Ctrl, both R-HCV and D-HCV had a significantly higher prevalence of acute transplant glomerulopathy (Ctrl, 6%; R-HCV, 55%, P<.0001; D-HCV 40%, P=.0004). Acute vascular rejection was more common in R-HCV (60%) than in Ctrl (28%) (P=.009) and the prevalence of chronic vascular rejection was also higher in R-HCV (60%) than in Ctrl (31%) (P=.01). Furthermore, chronic vascular rejection was diagnosed earlier in R- HCV(64% of cases within one month posttransplantation) than in Ctrl (19% within one month) (P=.01). Death censored renal allograft losses occurred in 14% of Ctrl, 17% of D-HCV, and 26% of R-HCV (not significant). In conclusion, R-HCV patients have a high prevalence of severe acute pathologic findings in renal allograft biopsies obtained early after transplantation and develop chronic vascular rejection more often and earlier than HCV negative recipients. These studies also confirm the previously reported association of HCV with acute transplant glomerulopathy.

AB - In the USA approximately 10% of candidates for renal transplantation have serum antibodies to hepatitis C (HCV). To assess the possible impact of HCV infection on early posttransplant events we assessed allograft complications during the first 6 months following renal transplantation in three groups of adult renal allograft recipients: (1) HCV antibody positive recipients (R-HCV) (n=32); (2) HCV negative recipients who received kidneys from HCV antibody positive donors (D-HCV) (n=48); and (3) HCV negative recipients of HCV negative allografts who were transplanted during the same time period as R-HCV (Ctrl) (n=204). Allograft biopsies were done for evaluation of allograft dysfunction during the first 6 months posttransplant in 58% of Ctrl, 42% of D-HCV, and 63% of R-HCV (not significantly different). The prevalence of acute tubulointerstitial rejection was similar among the 3 groups of patients. In contrast, compared with Ctrl, both R-HCV and D-HCV had a significantly higher prevalence of acute transplant glomerulopathy (Ctrl, 6%; R-HCV, 55%, P<.0001; D-HCV 40%, P=.0004). Acute vascular rejection was more common in R-HCV (60%) than in Ctrl (28%) (P=.009) and the prevalence of chronic vascular rejection was also higher in R-HCV (60%) than in Ctrl (31%) (P=.01). Furthermore, chronic vascular rejection was diagnosed earlier in R- HCV(64% of cases within one month posttransplantation) than in Ctrl (19% within one month) (P=.01). Death censored renal allograft losses occurred in 14% of Ctrl, 17% of D-HCV, and 26% of R-HCV (not significant). In conclusion, R-HCV patients have a high prevalence of severe acute pathologic findings in renal allograft biopsies obtained early after transplantation and develop chronic vascular rejection more often and earlier than HCV negative recipients. These studies also confirm the previously reported association of HCV with acute transplant glomerulopathy.

UR - http://www.scopus.com/inward/record.url?scp=0029861847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029861847&partnerID=8YFLogxK

U2 - 10.1097/00007890-199610270-00004

DO - 10.1097/00007890-199610270-00004

M3 - Article

VL - 62

SP - 1054

EP - 1059

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 8

ER -